Pharmaceutical Formulation & Drug Delivery

Transforming APIs into Robust, Patient-Centric Pharmaceutical Products

At HSP Research Group LLP, we provide science-driven pharmaceutical formulation and drug-delivery development services focused on converting active pharmaceutical ingredients (APIs) into stable, effective, manufacturable, and patient-friendly dosage forms.

Our formulation scientists apply principles of preformulation, pharmaceutics, biopharmaceutics, Quality by Design (QbD), DoE-based optimization, and drug-delivery science to develop formulations aligned with the intended route of administration, therapeutic objectives, patient needs, and regulatory expectations.

Our development approach integrates API–excipient compatibility, formulation screening, process optimization, critical quality attributes (CQAs), critical material attributes (CMAs), critical process parameters (CPPs), in-vitro performance testing, stability evaluation, scale-up, and technology transfer.